Literature DB >> 15288707

Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder.

Fabrice Duval1, Marc-Antoine Crocq, Marie-Sabine Guillon, Marie-Claude Mokrani, José Monreal, Paul Bailey, Jean-Paul Macher.   

Abstract

Evidence suggests that individuals with posttraumatic stress disorder (PTSD) have an enhanced sensitization of the hypothalamic--pituitary--adrenocortical (HPA) axis. However, few studies in adolescents have been performed. Fourteen sexually abused adolescent inpatients with DSM-IV PTSD (12 female, two male; mean +/- SD age, 16.2 +/- 1.9 years) were compared with 14 adolescent hospitalized controls (11 female, three male; mean age, 15.7 +/- 2.0 years). All subjects underwent a standard dexamethasone suppression test (DST, 1 mg given orally at 2300 h) five days after admission. Baseline blood samples were obtained at 0800 h, and the following day, adrenocorticotropin (ACTH) and cortisol levels were measured at 0800, 1600, and 2300 h. Clinical assessment included the Impact of Event Scale, Stanford Acute Stress Reaction Questionnaire, Beck Depression Inventory, and Coping Inventory for Stressful Situations. Post-DST ACTH levels were significantly lower in PTSD than in control adolescents (at 0800 h: P < 0.005; at 1600 h: P < 0.001; at 2300 h: P < 0.05). In patients, post-DST cortisol levels were reduced but not significantly. No correlations were found between ACTH and cortisol levels and time elapsed since trauma. These results demonstrate that sexually abused adolescents with PTSD show ACTH hypersuppression to DST suggesting enhanced glucocorticoid receptor sensitivity in the pituitary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288707     DOI: 10.1016/j.psyneuen.2004.03.006

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

1.  Violence, abuse, and asthma in Puerto Rican children.

Authors:  Robyn T Cohen; Glorisa J Canino; Hector R Bird; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

Review 2.  Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies.

Authors:  Jonathan DePierro; Lauren Lepow; Adriana Feder; Rachel Yehuda
Journal:  Biol Psychiatry       Date:  2019-07-24       Impact factor: 13.382

Review 3.  Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis.

Authors:  Matthew C Morris; Bruce E Compas; Judy Garber
Journal:  Clin Psychol Rev       Date:  2012-02-10

4.  Pilot Study on Childhood Sexual Abuse, Diurnal Cortisol Secretion, and Weight Loss in Bariatric Surgery Patients.

Authors:  Polly A Hulme; Corrigan L McBride; Kevin A Kupzyk; Jeffrey A French
Journal:  J Child Sex Abus       Date:  2015

5.  Patterns of endogenous steroids in apathetic refugee children are compatible with long-term stress.

Authors:  Hans Peter Söndergaard; Mark M Kushnir; Bernice Aronsson; Per Sandstedt; Jonas Bergquist
Journal:  BMC Res Notes       Date:  2012-06-19

6.  Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis.

Authors:  Sharain Suliman; Sian M J Hemmings; Soraya Seedat
Journal:  Front Integr Neurosci       Date:  2013-07-29

7.  Stress Across Generations: DNA Methylation as a Potential Mechanism Underlying Intergenerational Effects of Stress in Both Post-traumatic Stress Disorder and Pre-clinical Predator Stress Rodent Models.

Authors:  Sriya Bhattacharya; Audrey Fontaine; Phillip E MacCallum; James Drover; Jacqueline Blundell
Journal:  Front Behav Neurosci       Date:  2019-05-28       Impact factor: 3.558

Review 8.  Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders.

Authors:  Michael Notaras; Maarten van den Buuse
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.